Pharmaceutical News from PR Newswire |
|
 |
 |
|
|
|
<< [back to news list]
PDL BioPharma To Announce First Quarter 2009 Financial Results and Hold Conference Call May 7, 2009
|
INCLINE VILLAGE, Nev., April 30 /PRNewswire-FirstCall/ -- PDL
BioPharma, Inc. (PDL) (Nasdaq: PDLI) today announced that the company will
hold a conference call and webcast on Thursday, May 7 at 4:30 p.m. Eastern
Time to discuss its financial results for the first quarter of 2009 and
provide a business update. The call and webcast will follow the release of
the first quarter ended March 31, 2009 financial results after market
close.
Conference Call Details
To access the live conference call on May 7 via phone, please dial
(877) 361-8830 from the United States and Canada or (706) 679-8297
internationally. The conference ID is 97783926. Please dial in
approximately ten minutes prior to the start of the call. A telephone
replay will be available beginning approximately one hour after the call
through May 14, and may be accessed by dialing (800) 642-1687 from the
United States and Canada or (706) 645-9291 internationally. The replay
passcode is 97783926.
To access the live and subsequently archived webcast of the conference
call, go to the company's Web site at http://www.pdl.com and click
"Investors." Please connect to the web site at least 15 minutes prior to
the call to allow for any software download that may be necessary.
About PDL BioPharma
PDL BioPharma, Inc. pioneered the humanization of monoclonal antibodies
and, by doing so, enabled the discovery of a new generation of targeted
treatments for cancer and autoimmune diseases. PDL is focused on maximizing
the value of its antibody humanization patents and related assets. The
company receives royalties on sales of a number of humanized antibody
products marketed today, and also may receive royalty payments on
additional humanized antibody products launched before patent expiry in
late 2014. This press release and further information about PDL BioPharma,
Inc. can be found at: http://www.pdl.com.
NOTE: PDL BioPharma and the PDL BioPharma logo are considered
trademarks of PDL BioPharma, Inc.
|
